Clinical Bioequivalence of Wixela Inhub and Advair Diskus in Adults With Asthma.

Abstract Background: Wixela® Inhub® is a dry powder inhaler approved as a generic equivalent to Advair® Diskus® (fluticasone propionate [FP]/salmeterol fixed-dose combination) for patients with ast...